The first pharmaceutical therapy
for smell and taste loss.

At Cyrano Therapeutics, we’re dedicated to developing a therapy
for people dealing with long-term smell and taste loss.

This condition was estimated to affect over 15 million people in the US alone before the COVID-19 pandemic, 4 million of whom had lost their smell due to a flu virus. Since the pandemic, the number of patients with long-term smell loss from a virus has increased more than 10 fold, with thousands of new patients emerging each day.